Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Nephros (NEPH) over the last 11 years, with Q3 2025 value amounting to $15000.0.

  • Nephros' Asset Writedowns and Impairment fell 5588.24% to $15000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $104000.0, marking a year-over-year decrease of 7419.35%. This contributed to the annual value of $262000.0 for FY2024, which is 1118.64% down from last year.
  • Nephros' Asset Writedowns and Impairment amounted to $15000.0 in Q3 2025, which was down 5588.24% from $35000.0 recorded in Q2 2025.
  • In the past 5 years, Nephros' Asset Writedowns and Impairment registered a high of $1.3 million during Q3 2022, and its lowest value of $6000.0 during Q1 2025.
  • Over the past 5 years, Nephros' median Asset Writedowns and Impairment value was $49000.0 (recorded in 2022), while the average stood at $130647.1.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first soared by 276666.67% in 2021, then tumbled by 9178.08% in 2025.
  • Over the past 5 years, Nephros' Asset Writedowns and Impairment (Quarter) stood at $90000.0 in 2021, then skyrocketed by 1330.0% to $1.3 million in 2022, then crashed by 85.31% to $189000.0 in 2023, then tumbled by 74.6% to $48000.0 in 2024, then plummeted by 68.75% to $15000.0 in 2025.
  • Its Asset Writedowns and Impairment stands at $15000.0 for Q3 2025, versus $35000.0 for Q2 2025 and $6000.0 for Q1 2025.